Stay updated on Anifrolumab SubQ in Lupus Adults Clinical Trial
Sign up to get notified when there's something new on the Anifrolumab SubQ in Lupus Adults Clinical Trial page.

Latest updates to the Anifrolumab SubQ in Lupus Adults Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe history shows a new revision (Revision: v3.7.0) returned on 2026-09-10 with QC status Has Not Concluded. The history view now surfaces additional study record sections (More Information, Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Document Section, References, etc.), indicating an expanded data presentation for this study.SummaryDifference0.8%

- Check34 days agoChange DetectedA new revision entry 'Revision: v3.6.6' was added to the study's history and the previous 'Revision: v3.6.5' entry was removed. This reflects an updated version in the record history.SummaryDifference0.1%

- Check41 days agoChange DetectedThe history now shows 'Results Submitted' as the status and removes 'No Results Posted', indicating that the study results have been provided in the registry.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision label, v3.6.5, was added to the record history to reflect the latest update to the study record. The previous revision, v3.6.4, was removed from the current history view.SummaryDifference0.1%

- Check70 days agoChange DetectedA new version entry is added to the history with a label 'Study Status' and a revision update to v3.6.4. The older revision entry v3.6.3 from 2026-06-23 is removed.SummaryDifference0.3%

- Check98 days agoChange DetectedA new revision (v3.6.3) appears in the study history on 2026-06-23, and a Study Status entry was added on 2026-06-19. These are administrative updates to the history log rather than changes to the study data itself.SummaryDifference0.3%

Stay in the know with updates to Anifrolumab SubQ in Lupus Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anifrolumab SubQ in Lupus Adults Clinical Trial page.